Total and high-molecular weight adiponectin and risk of colorectal cancer: The European prospective investigation into cancer and nutrition study

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1211-1218

  Aleksandrova, Krasimira ^a   Boeing, Heiner ^a   Jenab, Mazda ^b   Bueno de Mesquita, H Bas ^c,d   Jansen, Eugene ^d   Van duijnhoven, Fränzel J B ^d,e   Fedirko, Veronika ^b   Rinaldi, Sabina ^b   Romieu, Isabelle ^b   Riboli, Elio ^f   Romaguera, Dora ^f   Westphal, Sabine ^g   Overvad, Kim ^h   Tjønneland, Anne ^i,j   Boutron Ruault, Marie Christine ^k,l   Clavel Chapelon, Françoise ^k,l   Kaaks, Rudolf ^m   Lukanova, Annekatrin ^m   Trichopoulou, Antonia ^n,o   Lagiou, Pagona ^n,p,q   Trichopoulos, Dimitrios ^p,q   Agnoli, Claudia ^r   Mattiello, Amalia ^s   Saieva, Calogero ^t   Vineis, Paolo ^f,u   Tumino, Rosario ^v   Peeters, Petra H ^c,f   Argüelles, Marcial ^w   Bonet, Catalina ^x   Sánchez, María José ^y   Dorronsoro, Miren ^z   Huerta, Jose María ^z   Barricarte, Aurelio ^z,aa   Palmqvist, Richard ^ab   Hallmans, Göran ^ac   Khaw, Kay Tee ^ad   Wareham, Nick ^ad   Allen, Naomi E ^ae   Crowe, Francesca L ^ae   Pischon, Tobias ^a,af   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^k INSERM   (France)

^l UNIVERSITÉ PARIS SACLAY   (France)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^o HELLENIC HEALTH FOUNDATION   (Greece)

^p HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^q BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^t CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^u Human Genetics Foundation   (Italy)

^v CIVILE M P AREZZO HOSPITAL   (Italy)

^w Health and Health Care Services Council   (Spain)

^x HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^y ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^z CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac UMEÅ UNIVERSITY   (Sweden)

^ad MEDICAL RESEARCH COUNCIL   (United Kingdom)

^ae UNIVERSITY OF OXFORD   (United Kingdom)

^af MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN SENSITIVITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECTUM CANCER; WAIST CIRCUMFERENCE;

ADIPONECTIN; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864294041     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs133     Document Type: Article

References (42)

1. Ning, Y. et al. (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes. Rev., 11, 19-30.
2. Khandekar, M.J. et al. (2011) Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer, 11, 886-895.
3. Kant, P. et al. (2011) Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nat. Rev. Gastroenterol. Hepatol., 8, 224-238.
4. Li, S. et al. (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 302, 179-188.
5. Chandran, M. et al. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care, 26, 2442-2450.
6. Gunter, M.J. et al. (2006) Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J. Nutr. Biochem., 17, 145-156.
7. Brochu-Gaudreau, K. et al. (2010) Adiponectin action from head to toe. Endocrine, 37, 11-32.
8. Kim, A.Y. et al. (2010) Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol. Endocrinol., 24, 1441-1452.
9. Byeon, J.S. et al. (2010) Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int. J. Cancer., 127, 2758-2767.
10. Barb, D. et al. (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr., 86, s858-s866.
11. Kelesidis, I. et al. (2006) Adiponectin and cancer: a systematic review. Br. J. Cancer, 94, 1221-1225.
12. Xu, X.T. et al. (2011) Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J. Dig. Dis., 12, 234-244.
13. An, W. et al. (2012) Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur. J. Cancer Prev., 21, 126-133.
14. Wei, E.K. et al. (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl Cancer Inst., 97, 1688-1694.
15. Lukanova, A. et al. (2006) Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 15, 401-402.
16. Neumeier, M. et al. (2006) Different effects of adiponectin isoforms in human monocytic cells. J. Leukoc. Biol., 79, 803-808.
17. Riboli, E. et al. (1997) The EPIC project: rationale and study design. European prospective investigation into cancer and nutrition. Int. J. Epidemiol., 26 (suppl. 1), S6-S14.
18. Riboli, E. et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr., 5, 1113-1124.
19. Aleksandrova, K. et al. (2010) Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am. J. Epidemiol., 172, 407-418.
20. Prentice, R.L.B.N. (1978) Retrospective studies and failure time models. Biometrika, 65, 153-158.
21. Alberti, K.G.Z.P. et al. (2005) IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet, 366, 1059-1062.
22. Ahima, R.S. (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring), 14 (suppl. 5), 242S-249S.
23. Pischon, T. et al. (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl Cancer Inst., 98, 920-931.
24. Heidemann, C. et al. (2008) Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med., 149, 307-316.
25. Ogorodnikova, A.D. et al. (2010) High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke, 41, 1376-1381.
26. Sattar, N. et al. (2008) Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J. Clin. Endocrinol. Metab., 93, 3299-3301.
27. Sattar, N. et al. (2008) High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. J. Clin. Endocrinol. Metab., 93, 1846-1849.
28. Rubenstein, J.H. et al. (2009) Association of adiponectin multimers with Barrett's oesophagus. Gut, 58, 1583-1589.
29. Schober, F. et al. (2007) Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem. Biophys. Res. Commun., 361, 968-973.
30. Kovacova, Z. et al. (2011) The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int. J. Obes. (Lond.). doi: 10.1038/ijo.2011.223.
31. Halberg, N. et al. (2009) Systemic fate of the adipocyte-derived factor adiponectin. Diabetes, 58, 1961-1970.
32. Kaklamani, V.G. et al. (2008) Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 300, 1523-1531.
33. Pechlivanis, S. et al. (2009) Genetic variation in adipokine genes and risk of colorectal cancer. Eur. J. Endocrinol., 160, 933-940.
34. Giovannucci, E. (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am. J. Clin. Nutr., 86, s836-s842.
35. van Duijnhoven, F.J. et al. (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut, 60, 1094-1102.
36. Mantzoros, C. et al. (2004) Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab., 89, 1102-1107.
37. Rinaldi, S.R.S. et al. (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev., 17, 3108-3115.
38. Tilg, H. et al. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol., 6, 772-783.
39. Pischon, T. et al. (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin. Chem., 49, 650-652.
40. Bluher, M. et al. (2007) Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care, 30, 280-285.
41. Pischon, T. et al. (2011) Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis, 219, 322-329.
42. Zhu, N. et al. (2010) High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J. Clin. Endocrinol. Metab., 95, 5097-5104.